Tardive akathisia: An analysis of clinical features and response to open therapeutic trials

Movement Disorders

Volumn 4, Issue 2, 1989, Pages 157-175

  Burke, Robert E ^a   Kang, Un Jung ^a,b   Jankovic, Joseph ^c   Miller, Lucinda G ^c   Fahn, Stanley ^a  

^a Columbia University ^*  (United States)

^b BURKE REHABILITATION HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dopamine antagonists; Tardive akathisia

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; HALOPERIDOL; LEVODOPA; LOXAPINE; METOCLOPRAMIDE; MOLINDONE; PERPHENAZINE; PROPRANOLOL; RESERPINE; TETRABENAZINE; THIORIDAZINE;

ADULT; AKATHISIA; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGICAL ASPECT; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ADULT; AGED; AGED, 80 AND OVER; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; BRAIN; DISABILITY EVALUATION; DOPAMINE ANTAGONISTS; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMAN; MALE; MIDDLE AGE; MOTOR SKILLS; PROGNOSIS; PSYCHOMOTOR AGITATION; RECEPTORS, DOPAMINE; RETROSPECTIVE STUDIES; STEREOTYPED BEHAVIOR; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024598720     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.870040208     Document Type: Article

References (51)

1. Akathisie
2. Nouvelles remarques sur l'akathisia
3. Akathisia and tasikinesia
4. Ueber einige Bemerkenswerte begleiterscheinunger der extrapyramidalen Rigiditat (Akathisie‐Mikographic‐Kinesia Paradoxa)
5. Neurological reactions to psychotropic drugs
6. Motor disorders induced by neuroleptics
7. American College of Neuropsychopharmacology: Food and Drug Administration Task Force. Neurologic syndromes associated with antipsychotic drug use
8. Drug‐induced extrapyramidal disorders
9. Drug‐induced disorders of movement
10. The many faces of akathisia
11. Akathisia with haloperidol and thiothixene
12. Akathisia variants and tardive dyskinesia
13. The clinical phenomenon of akathisia
14. Neurotoxicology of major tranquilizers
15. Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples
16. Akathisia and tardive dyskinesia
17. A survey of drug‐induced extrapyramidal reactions
18. A medical student's experience with akathisia
19. Clinical forms of severe tardive dyskinesia
20. Akathisia: a side effect to be remembered
21. An unusual case of akathisia
22. Akathisia: an overlooked, distressing, but treatable condition
23. Suicide attempts associated with akathisia
24. Three cases of akathisia and “acting out”
25. Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions
26. Tardive dyskinesia: current clinical issues
27. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy
28. Chronic involuntary movements induced by phenothiazines
29. An apparently irreversible syndrome of abnormal movements following phenothiazine medication
30. Persistent muscular restlessness after phenothiazine treatment: report of three cases
31. Late‐onset akathisia—an indicant of covert dyskinesia: two case reports
32. Persistent akathisia following neuroleptic withdrawal
33. Tardive akathisia and agitated depression during metoclopramide therapy
34. Persistent akathisia associated with early tardive dyskinesia
35. Natural history and treatment of tardive dystonia
36. Incidence of tardive dyskinesia: five‐year data from a prospective study
37. The phenomenology of tics
38. Spontaneous buccolinguofacial dyskinesia in the elderly
39. Spontaneous dyskinesias vs. neuroleptic‐induced dyskinesias in 270 elderly subjects
40. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration
41. Changes in prevalence, severity, and recovery in tardive dyskinesia with age
42. Restless legs syndrome
43. Tetrabenazine therapy of dystonia, chorea, tics and other dyskinesias
44. Tardive dystonia: late‐onset and persistent dystonia caused by antipsychotic drugs
45. Opioid responsiveness in patients with neurolepticinduced akathisia
46. Propranolol in the treatment of neurolepticinduced akathisia
47. Noradrenergic mechanisms in akathisia: treatment with propranolol and clonidine
48. Dopamine‐containing innervation of the striatum: subsystems and their striatal correspondents
49. Brain neurotransmitter changes in Parkinson's disease
50. The clinical syndrome of striatal dopamine deficiency